|
|  |
|
|
Potent antiretroviral activity of dOTC (BCH-10652) in HIV-1-infected patients: Initial results from a phase I/II clinical trial.
|
|
 |
|
|
Originally Published on February 1, 2000
Wood, R., Trope, B., Van Leeuwen, R. W., Martin, D. E., and Proulx, L.
39th Interscience Conference on Antimicrobial Agents and Chemotherapy, San Francisco, September 26-29, 1999. Abstract 503.
ABSTRACT:
Not available.
|
|
|
|
| |
Copyright © 1997–2003, Vertibrae, Inc. and HIVresistanceWeb. All rights reserved. | Privacy Policy |
|
